Best Practices in Treating Polyposis Conditions

A six-part, webinar series: presented live in 2014
ON-DEMAND now available

Webinar Series Overview

We would like to thank 

Ambry Genetics


Cancer Prevention Pharmaceuticals


Myriad Genetics

for their generous grant support of this educational activity.

As part of the Hereditary Colon Cancer Foundation's commitment to improve the quality of care for our patient population, we hosted an AGA Institute endorsed, live, six-part, webinar series discussing key issues and best practices in treating polyposis conditions. Topics of discussion emphasized familial adenomatous polyposis (FAP), attenuated FAP, and MUTYH associated polyposis. This series is endorsed by the Collaborative Group of the America on Inherited Colorectal Cancer (CGA-ICC), the American Gastroenterological Association (AGA), and the National Society of Genetic Counselors (NSGC).


On-Demand replay is now available.



Target Audience


Clinicians, including primary care physicians and gastroenterologists, physician assistants, and certified gastroenterology registered nurses interested in enhancing their knowledge of polyposis conditions; colorectal surgeons interested in broadening their understanding of polyposis conditions and how they relate to bowel diversions; basic and translational researchers and fellows in the fields of gastroenterology and gastrointestinal oncology; genetic counselors who provide care to patients with polyposis conditions or are interested in expanding their scope of care to genetic bowel cancers.



Webinar Presenters (Click Here for Bios)


  • Carol Burke, MD, of the Cleveland Clinic

  • James Church, MD, of the Cleveland Clini

  • Michael Hall, MD, MS, at the Fox Chase Cancer Center

  • Brandie Leach, MS, LGC, of the Cleveland Clinic

  • Deb Neklason, PhD, at the University of Utah Huntsman Cancer Institute

  • Douglas Riegert-Johnson, MD, at Mayo Clinic, Jacksonville, FL

  • Elena Stoffel, MD, MPH, at the University of Michigan

  • Paul Wise, MD, at the Washington University - St. Louis



Learning Outcomes


At the conclusion of this webinar series, participants will be able to:


  • Follow best practices for screening and treating their polyposis patients.

  • Locate best practice resources for screening and treating their polyposis patients.

  • Incorporate recent hereditary colorectal cancer research results.


Click on each webinar name for specific learning outcomes.



Registration Information


6 Part Webinar Series: $40*



CEU Information



The National Society of Genetic Counselors (NSGC) has authorized the Hereditary Colon Cancer Foundation to offer up to 0.6 CEUs or 6.0 contact hours (Category 1) for Preparing to Treat Polyposis Conditions. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of certification and recertification. 


*At the time of registration, a one time $25 fee will be added for the individual's application to the NSGC for CEUs. 


Refund Policy


Registration fees cover the cost of CEUs, production and promotion of the webinar series. Proceeds benefit the Hereditary Colon Cancer Foundation. If you would like to receive a refund, please email prior to viewing 2 webinars. Refunds will exclude a 10% processing fee.